Yin, Dwight E.; Ludema, Christina; Cole, Stephen R.; Golin, Carol E.; Miller, William C.; Warshaw, Meredith G.; McKinney Jr., Ross E.; Mussi-Pinhata, Marisa Márcia 
Source: PLOS ONE. Unidade: FMRP
Subjects: TERAPIA ANTIRRETROVIRAL DE ALTA ATIVIDADE, FARMACOTERAPIA, PEDIATRIA, HIV, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YIN, Dwight E. et al. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLOS ONE, v. 15, n. 11, p. 1-18, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0242405. Acesso em: 02 nov. 2025.APA
Yin, D. E., Ludema, C., Cole, S. R., Golin, C. E., Miller, W. C., Warshaw, M. G., et al. (2020). Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLOS ONE, 15( 11), 1-18. doi:10.1371/journal.pone.0242405NLM
Yin DE, Ludema C, Cole SR, Golin CE, Miller WC, Warshaw MG, McKinney Jr. RE, Mussi-Pinhata MM. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors [Internet]. PLOS ONE. 2020 ; 15( 11): 1-18.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1371/journal.pone.0242405Vancouver
Yin DE, Ludema C, Cole SR, Golin CE, Miller WC, Warshaw MG, McKinney Jr. RE, Mussi-Pinhata MM. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors [Internet]. PLOS ONE. 2020 ; 15( 11): 1-18.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1371/journal.pone.0242405
